Impact of Lateral Bone Grafting With Intraoperative Fusion in ACDF on Clinical Outcomes
Launched by XUANWU HOSPITAL, BEIJING · Aug 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new method of surgery for patients with cervical spondylosis, a condition affecting the neck. Specifically, it is studying the use of a special type of bone graft during a procedure called Anterior Cervical Discectomy and Fusion (ACDF). The goal is to see if this new approach can help bones heal better and improve patients' overall health after surgery.
To participate in this trial, you need to be between 18 and 60 years old and have cervical spondylosis that requires surgery on 1-2 segments of your neck. You also need to agree to the surgery and be willing to return for follow-up visits over time. However, certain health conditions may exclude you, such as severe heart or lung issues, or if you're pregnant or recently involved in another clinical trial. If you join, you can expect close monitoring of your recovery and health outcomes after the surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18-60 years old; patients with cervical spondylosis who were about to undergo 1-2 segment ACDF surgery; agreement with the surgical plan and willingness to undergo long-term clinical follow-up; and signing of an informed consent form.
- Exclusion Criteria:
- • Drug or alcohol abusers; those with abnormal liver or kidney function unsuitable for surgery; those with cardiac insufficiency unsuitable for surgery; those with severe metabolic and endocrine diseases unsuitable for surgery; those with severe lung disorders such as asthma and abnormal lung function unsuitable for surgery; pregnant and breastfeeding women as well as those who are planning to become pregnant in the near future; those who have participated in other clinical trials within 3 months; and those who are not suitable for participation in the experiment in the opinion of the investigator.
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Fengzeng Jian, MD, PhD
Study Chair
Xuanwu Hospital, Beijing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported